市場調查報告書
商品編碼
1395748
機械人工呼吸器全球市場規模、佔有率、行業趨勢分析報告:按模式、按組件、按產品類型、按年齡層、按最終用戶、按地區、展望和預測,2023-2030 年Global Mechanical Ventilators Market Size, Share & Industry Trends Analysis Report By Mode, By Component, By Product Type, By Age Group (Adult, Geriatric, and Pediatric & Neonatal), By End User, By Regional Outlook and Forecast, 2023 - 2030 |
預計到 2030 年,機械人工呼吸器市場規模將達到 167 億美元,預測期內年複合成長率為 12.6%。 2022年市場規模為103.94萬台,成長率為27.4%(2019-2022年)。
根據 KBV Cardinal 矩陣中的分析,美敦力 PLC 是市場先驅。例如,2022 年 4 月,美敦力 (Medtronic) PLC 與 GE Healthcare 合作,專注於門診手術中心 (ASC) 和辦公室實驗室 (OBL) 的獨特護理需求和需求。這種合作關係為客戶提供了廣泛的產品系列、金融解決方案和卓越的服務。通用電氣 (GE)、Koninklijke Philips NV 和 Dragerwerk AG &Co.KGaA 等公司是市場上的主要創新者。
COVID-19 影響分析
COVID-19 對市場最直接、最明顯的影響是對這些救生設備的需求空前激增。隨著病毒迅速傳播並使各國醫療保健系統不堪重負,支持重症患者的人工呼吸器嚴重短缺。醫院和醫療機構必須增加人工呼吸器容量,以應對湧入的 COVID-19 患者。 COVID-19 加速了遠端監控和遠端醫療解決方案的採用,包括將人工呼吸器整合到遠端醫療網路中。儘管這些設計缺乏傳統人工呼吸器的一些先進功能,但它們專注於滿足需求激增的基本功能。雖然這些創新提供了短期緩解,但它們也引發了人們對快速開發的設備的品質和安全性的擔憂。因此,COVID-19大流行對市場產生了正面影響。
市場成長要素
呼吸道疾病盛行率上升
慢性阻塞性肺病、氣喘和間質性肺病等呼吸系統疾病在高齡化族群中尤其常見。這些疾病往往需要長期或間歇性的機械通氣支持,產生了對機械人工呼吸器的持續需求。心臟衰竭和神經肌肉疾病等多種慢性疾病可能導致呼吸系統併發症,需要機械通氣才能達到最佳的患者護理。這些疾病的同時發生增加了對人工呼吸器的需求。呼吸窘迫症候群和支氣管炎等兒童和新生兒呼吸系統疾病的流行需要專門的新生兒和兒童用人工呼吸器。呼吸系統疾病的流行正在推動機械人工呼吸器與遠端醫療網路和遠端監控技術的整合。這將使醫療保健提供者能夠遠端監測患有呼吸道疾病的患者並調整人工呼吸器設置,從而改善獲得護理的機會。呼吸道疾病盛行率上升是市場成長的關鍵因素。
擴大家庭通風計劃
家庭通風計畫正在增加家庭環境中對機械人工呼吸器的需求。這些人工呼吸器緊湊、易於使用,而且通常易於操作,適合患者和看護者。患有慢性呼吸系統疾病(如慢性阻塞性肺病、神經肌肉疾病和肥胖通氣不足綜合症)的患者可能需要長期機械通氣支持。家庭通氣計劃為這些患者提供了解決方案,並延長了呼吸器的使用範圍。家用人工呼吸器的設計考慮了患者的舒適度。家庭通氣計劃通常包含遠端醫療,使患者能夠遠端獲得專家諮詢。這對於偏遠和服務欠缺地區的患者尤其重要。家庭通風計畫的擴大一直是推動市場成長的關鍵因素。
市場抑制因素
支援鏈中斷阻礙及時生產和供應
支援鏈中斷使製造商難以及時生產並向醫療機構交付人工呼吸器。需求增加和支援鏈中斷可能會延遲向有需要的患者提供救生設備。供不應求推高了機械人工呼吸器的價格,使醫療機構難以負擔得起,特別是在資源有限的環境中。成本上升使醫療保健提供者的預算緊張。在某些情況下,支援鏈中斷可能會加快人工呼吸器的採購速度並損害所購買設備的品質。資源分配決策對臨床醫師來說是一種精神負擔。支援鏈中斷可能會導致物流挑戰,包括將人工呼吸器運送到醫療機構的延誤以及有效儲存和分配的困難。因此,阻礙及時生產和交付的支援鏈中斷可能會減緩市場成長。
按模式分類的展望
依模式分類,市場分為侵入性通氣和非侵入性通氣。 2022 年,有創通氣細分市場收益佔有率最大。侵入性通氣用於各種臨床應用,包括 ICU、手術室、急診室和術後恢復。這種多功能性確保了對侵入性人工呼吸器的穩定需求。有創人工呼吸器配備先進的監測和警報系統,確保病人安全。這包括追蹤氣道壓力、潮氣量和氧氣濃度等參數。有創通氣對於遭受創傷、瀕臨溺水或正在經歷其他危及生命的緊急情況的患者至關重要。這些患者可能需要立即插管和機械通氣。
組件展望
按組件分類,市場分為設備和服務。 2022 年,服務業在市場中獲得了顯著的收益佔有率。醫療機構通常需要專業協助來正確安裝和設置機械人工呼吸器。當醫護人員遇到人工呼吸器問題時,技術支援和服務台服務可以及時提供協助。這種支持可以快速解決問題並最大限度地減少對患者照護的干擾。一些服務供應商提供遠端監控和故障排除功能,使您可以遠端存取人工呼吸器並診斷問題。這減少了現場服務聯絡人的數量並加快了問題的解決速度。
產品類型展望
按產品類型分類,市場分為加護病房/重症患者、運輸/攜帶式/門診和新生兒。 2022年,加護病房/重症患者監護細分市場佔市場最高銷售佔有率。在加護病房/重症患者護理領域,機械人工呼吸器用於多種情況,包括呼吸衰竭、創傷、感染疾病和手術恢復。 ICU 經常管理患有慢性呼吸道疾病(例如慢性阻塞性肺病)的患者,這些患者在急性發作期間可能需要機械通氣支持。這種類型的慢性護理有助於加護病房/重症加護領域的持續需求。
年齡層展望
按年齡層別分類,市場分為成人、老年人和兒童/新生兒。在 2022 年的市場中,老年人細分市場佔據了重要的收益佔有率。老年人更容易罹患與老齡化相關的呼吸道疾病,如慢性阻塞性肺病、肺炎和阻塞型睡眠呼吸中止症。老年患者通常患有多種合併症,這可能會使呼吸系統疾病複雜化並增加機械通氣的需求。常見的合併症包括心臟病、糖尿病和神經病變。許多老年人需要針對各種情況進行手術干涉,包括心血管手術和髖置換術。老年患者在術後恢復期間可能需要機械通氣,增加了對人工呼吸器的需求。
最終用戶前景
依最終用戶分類,市場分為醫院/診所、門診手術中心、居家醫療等。 2022年,醫院和診所細分市場以最高的收益佔有率引領市場。醫院和診所部門是慢性呼吸道疾病患者管理的核心。機械人工呼吸器對於神經肌肉疾病和嚴重氣喘患者至關重要。醫院和診所經常使用運輸人工呼吸器在病房、部門和醫療機構之間安全地轉移患者,同時保持足夠的通風。醫院經常提供家庭通氣服務,將機械人工呼吸器的使用擴展到病人家中。這包括為患者及其看護者提供攜帶式通氣設備和培訓。
區域展望
從區域來看,我們對北美、歐洲、亞太地區和拉丁美洲地區的市場進行了分析。 2022年,北美地區以最高的收益佔有率引領市場。北美,特別是美國和加拿大,人口正在迅速高齡化。老年人更容易患呼吸道疾病,並且可能需要人工呼吸來治療各種疾病。北美慢性阻塞性肺病和氣喘等慢性呼吸道疾病的盛行率很高。機械人工呼吸器對於這些疾病的治療至關重要,尤其是在病情惡化期間。
The Global Mechanical Ventilators Market size is expected to reach $16.7 billion by 2030, rising at a market growth of 12.6% CAGR during the forecast period. In the year 2022, the market attained a volume of 1,039.4 thousand units, experiencing a growth of 27.4% (2019-2022).
As per the World Health Organisation, one in six people will be 60 or older by 2030. The number of people 60 and older in the world will increase from 1 billion in 2020 to 1.4 billion in 2050. By 2050, there will be 2.1 billion people in the world who are 60 or older. Mechanical ventilators are essential for managing these age-related respiratory issues. Consequently, the Geriatric segment captured $2,172.9 million revenue in the market in 2022. It plays a vital role in enhancing the quality of life for older adults by providing advanced respiratory support tailored to their physiological nuances. The elderly population is susceptible to respiratory complications due to weakened respiratory muscles, decreased lung function, and comorbidities.
The major strategies followed by the market participants are Partnerships, Collaborations & Agreements as the key developmental strategy to keep pace with the changing demands of end users. For instance, In June, 2023, Koninklijke Philips N.V. collaborated with Biotronik, aimed to widen the range of cardiovascular devices available for Philips SymphonySuite customers. Additionally, ZOLL Medical Corporation teamed up with Cogmedix, aimed to boost the production of ventilators during the COVID-19 pandemic.
Based on the Analysis presented in the KBV Cardinal matrix; Medtronic PLC is the forerunners in the Market. For Instance, In April, 2022, Medtronic PLC collaborated with GE Healthcare focused on the unique needs and demand for care at Ambulatory Surgery Centers (ASCs) and Office Based Labs (OBLs). Under this collaboration, customers can access extensive product portfolios, financial solutions, and exceptional service. Companies such as General Electric (GE) Co., Koninklijke Philips N.V., Dragerwerk AG & Co. KGaA are some of the key innovators in Market.
COVID-19 Impact Analysis
The most immediate and visible impact of COVID-19 on the market was the unprecedented surge in demand for these life-saving devices. As the virus rapidly spread and overwhelmed healthcare systems in various countries, there was a significant shortage of ventilators to support critically ill patients. Hospitals and healthcare facilities faced an acute need to increase their ventilator capacity to manage the influx of COVID-19 patients. COVID-19 accelerated the adoption of remote monitoring and telehealth solutions, including integrating ventilators into telemedicine networks. These designs focused on essential functions to address the surge in demand, even if they lacked some of the advanced features of traditional ventilators. While these innovations provided short-term relief, they also raised concerns about the quality and safety of rapidly developed devices. Thus, the COVID-19 pandemic had a positive effect on the market.
Market Growth Factors
Rising prevalence of respiratory diseases
Respiratory diseases such as COPD, asthma, and interstitial lung diseases are highly prevalent, particularly in aging populations. These conditions often require long-term or intermittent ventilatory support, creating a sustained demand for mechanical ventilators. Various chronic conditions, such as heart failure and neuromuscular disorders, can result in respiratory complications that require mechanical ventilation for optimal patient care. The co-occurrence of these conditions adds to the demand for ventilators. The prevalence of pediatric and neonatal respiratory disorders, such as respiratory distress syndrome and bronchiolitis, necessitates specialized neonatal and pediatric ventilators. The prevalence of respiratory diseases has driven the integration of mechanical ventilators with telemedicine networks and remote monitoring technologies. This permits healthcare providers to remotely monitor patients with respiratory conditions and adjust ventilator settings, improving access to care. The rising prevalence of respiratory diseases is a significant driver of growth in the market.
Expansion of home ventilation programs
Home ventilation programs create a growing demand for mechanical ventilators in home settings. These ventilators are often more compact, user-friendly, and easy to operate, making them suitable for patients and caregivers. Patients with chronic respiratory conditions, such as COPD, neuromuscular disorders, and obesity hypoventilation syndrome, may require long-term ventilatory support. Home ventilation programs provide a solution for these patients, extending the use of ventilators. Home ventilators are designed with a focus on patient comfort. Telemedicine is frequently integrated into home ventilation programs, allowing patients to access specialist consultations remotely. This is especially important for patients in remote or underserved areas. The expansion of home ventilation programs has been a pivotal factor in driving the growth of the market.
Market Restraining Factors
Supply chain disruptions hampering timely production and delivery
Supply chain disruptions can make it challenging for manufacturers to produce and deliver ventilators to healthcare facilities in a timely manner. Increased demand and supply chain disruptions can delay the provision of life-saving equipment to needy patients. Shortages can drive up the prices of mechanical ventilators, making them less affordable for healthcare facilities, especially in resource-constrained settings. Higher costs can strain the budgets of healthcare providers. In some cases, supply chain disruptions can lead to a rush to procure ventilators, potentially compromising the quality of devices purchased. Decisions about resource allocation can be emotionally taxing for clinicians. The disruption of the supply chain can result in logistical challenges, including delays in transporting ventilators to healthcare facilities and difficulties in storing and distributing them effectively. Thus, supply chain disruptions hampering timely production and delivery can slow down the growth of the market.
Mode Outlook
Based on mode, the market is divided into invasive ventilation and non-invasive ventilation. In 2022, the invasive ventilation segment registered the maximum revenue share in the market. Invasive ventilation is utilized across various clinical applications, including ICUs, operating rooms, emergency departments, and post-operative recovery. This versatility ensures consistent demand for invasive ventilators. Invasive ventilators are equipped with advanced monitoring and alarm systems to ensure patient safety. This includes tracking parameters such as airway pressure, tidal volume, and oxygen levels. Invasive ventilation is crucial for patients who have suffered traumatic injuries, near-drowning incidents, or other life-threatening emergencies. These patients may require immediate intubation and mechanical ventilation.
Component Outlook
On the basis of component, the market is bifurcated into devices and services. The services segment garnered a significant revenue share in the market in 2022. Healthcare facilities often require professional assistance for the proper installation and setup of mechanical ventilators. Technical support and help desk services provide timely assistance to healthcare providers when they encounter issues with ventilators. This support ensures quick problem resolution and minimizes disruptions in patient care. Some service providers offer remote monitoring and troubleshooting capabilities, allowing them to access ventilators and diagnose issues from a distance. This can decrease the number of on-site service contacts and expedite the resolution of issues.
Product Type Outlook
By product type, the market is categorized into intensive care unit/critical care, transport/portable/ambulatory, and neonatal care. In 2022, the intensive care unit/critical care segment held the highest revenue share in the market. The intensive care unit/critical care segment utilizes mechanical ventilators for a wide range of conditions, including respiratory failure, trauma, infections, surgery recovery, and more. ICUs often manage patients with chronic respiratory conditions, such as COPD, who may require ventilatory support during acute exacerbations. This chronic care aspect contributes to sustained demand in the intensive care unit /critical care segment.
Age Group Outlook
Based on age group, the market is classified into adult, geriatric, and pediatric & neonatal. The geriatric segment acquired a substantial revenue share in the market in 2022. Elderly individuals are more prone to age-related respiratory conditions, such as COPD, pneumonia, and obstructive sleep apnea. Geriatric patients often have multiple comorbidities, which can complicate respiratory conditions and lead to a greater need for mechanical ventilation. Common comorbidities include heart disease, diabetes, and neurological disorders. Many elderly individuals require surgical interventions for various medical conditions, such as heart surgery or hip replacement. Post-surgical mechanical ventilation may be necessary for geriatric patients during their recovery, contributing to the demand for ventilators.
End User Outlook
By end user, the market is fragmented into hospital & clinic, ambulatory surgical center, home care, and others. In 2022, the hospital & clinic segment led the market by generating highest revenue share. Hospitals & clinics segment are central in managing patients with chronic respiratory conditions. Mechanical ventilators are essential for patients with neuromuscular disorders or severe asthma. Hospitals & clinics often use transport ventilators to safely transfer patients between units, departments, or healthcare facilities while maintaining proper ventilation. Hospitals often provide home ventilation services, extending the use of mechanical ventilators into patients' homes. This includes the provision of portable ventilators and training for patients and their caregivers.
Regional Outlook
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. North America, particularly the United States and Canada, has a rapidly aging population. The elderly are more susceptible to respiratory illnesses and may require mechanical ventilation for various medical conditions. North America has a high prevalence of chronic respiratory diseases such as COPD and asthma. Mechanical ventilators are essential for managing these conditions, especially during exacerbations.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GE HealthCare Technologies, Inc., Koninklijke Philips N.V., Medtronic PLC, Dragerwerk AG & Co. KGaA, Getinge AB, Asahi Kasei Corporation (Zoll Medical Corporation), Hamilton Medical AG (Hamilton Bonaduz AG), Carl Reiner GmbH, Mindray Medical International Limited and Vyaire Medical, Inc.
Recent Strategies Deployed in Mechanical Ventilators Market
Partnerships, Collaborations & Agreements:
Oct-2023: Mindray Medical International Limited announced a partnership with Edwards Lifesciences, a global leader in medical innovations. This collaboration made Mindray's BeneVision N-Series the initial patient monitoring system to integrate with Edwards FloTrac sensor for hemodynamic monitoring in the North American market, after their joint launch in China in 2022.
Sep-2023: Medtronic Canada ULC, a subsidiary of Medtronic PLC, partnered with FluidAI Medical, a notable AI startup. Their collaboration aimed to revolutionize Canadian healthcare through the Continuous Connected Patient Care (CCPC) project under Canada's DIGITAL Global Innovation Cluster for digital technologies.
Jul-2023: Mindray Medical International Limited and SingHealth signed a memorandum of understanding aimed at delivering high-quality, accessible patient care. The partnership focused on medical training, academic platform development, and facilitating international exchanges on clinical topics. This collaboration aims to promote knowledge sharing and advance global healthcare.
Jun-2023: Koninklijke Philips N.V. collaborated with Biotronik, a multi-national cardiovascular biomedical research and technology company. This collaboration aimed to widen the range of cardiovascular devices available for Philips SymphonySuite customers.
May-2023: Mindray Medical International Limited signed a strategic agreement with Vithas, a GMP-certified chemical analysis contract lab, allowing Vithas to integrate innovative patient monitoring technology in its 20 hospitals. The partnership aimed to enhance patient safety in critical areas, including the ICU, post-anesthesia recovery, operating rooms, and emergencies.
Apr-2022: Medtronic PLC collaborated with GE Healthcare focused on the unique needs and demand for care at Ambulatory Surgery Centers (ASCs) and Office Based Labs (OBLs). Under this new collaboration, customers can access extensive product portfolios, financial solutions, and exceptional service.
Mar-2022: Asahi Kasei Corporation has teamed up with Genomatica, Inc., a company specializing in biological manufacturing processes for chemicals. Their collaboration is focused on bringing renewable nylon 6,61, created from Genomatica's bio-based HMD building block, to market. This partnership also aligns with Asahi Kasei's goal to be a pioneer in offering eco-friendly nylon 6,6 for the automotive and electronics sectors using plant-based HMD, thereby advancing their sustainability objectives.
Jan-2021: Drager Distribution extended its agreement with Breas Medical. Through this agreement, the companies aimed to supply LTACs and SNFspproch with comprehensive ventilation solutions, cost-effective, designed to improve patient health.
Nov-2020: ZOLL Medical Corporation, a medical devices manufacturer and a member of Asahi Kasei Corporation, teamed up with Cogmedix, provides FDA and ISO 13485 compliant product development and commercialization services. The companies aimed to boost the production of ventilators during the COVID-19 pandemic.
Jun-2020: Medtronic PLC formed a partnership with Foxconn, a multinational electronics contract manufacturer. The companies aimed to enlarge ventilator supply for more patients and hospitals than any other company can do individually.
May-2020: Vyaire Medical collaborated with Spirit AeroSystems, the world's largest manufacturers of aerostructures. Together, the companies aimed to construct critical care ventilators at a transformed space in Wichita, Kan. Moreover, this partnership would permit Vyaire to ramp up rapidly in the production of critical care ventilators.
Apr-2020: GE Healthcare teamed up with Microsoft, an American multinational technology corporation. Together, the companies aimed to launch a new software solution, Mural Virtual Care Solution. This software would give a wide view of the crowd around their ventilated patient and the risk of deterioration.
Apr-2020: Philips formed a partnership with Flex as well as Jabil. The partnership aimed to fast-track the production of ventilators and boost overall supply.
Apr-2020: Royal Philips collaborated with the U.S. Government. The entities aimed to enlarge the production of hospital ventilators, manufacturing in the U.S to save lives all around.
Apr-2020: Vyaire Medical came into a contract of $407 million with Health and Human Services. The companies aimed to construct 22,000 ventilators in the coronavirus pandemic. The entities aimed to increase the production and ramp up the delivery of essential medical equipment required.
Apr-2020: Vyaire Medical received a contract of USD $50 million with the Brazilian Ministry of Health. The companies aimed to construct 4,300 iX5 ventilators during the pandemic. The entities aimed to ramp up manufacturing capacity across the globe to ensure a sufficient supply of ventilators and associated consumables at this crucial time.
Mar-2020: GE Healthcare joined hands with Ford Motor Company, an American multinational automobile manufacturer. The companies focused on growing up the production of ventilators and medical equipment to cure COVID-19 respiratory illness patients.
Mar-2020: Dragerwerk formed a partnership with Babock, international aerospace, defense, and Security Company. This partnership aimed to help in the development of ventilators for the ITV News and NHS.
Product Launches and Expansions:
Jan-2023: Getinge AB launched the Servo-C mechanical ventilator, offering lung-protective tools for pediatric and adult patients in selected markets. With modular components for smart fleet management, the launch aimed to enhance global healthcare accessibility and affordability. Features included CO2 monitoring and a servo compass for visualizing volume and pressure targets.
Mar-2022: ZOLL Medical Corporation, a subsidiary of Asahi Kasei, introduced the ZOLL Arrhythmia Management System (AMS). The system incorporated biometric data with traditional MCT devices, enhancing ECG information. A recent study affirmed that ZOLL AMS assists physicians in creating more informed patient treatment plans.
Oct-2021: Drager introduced the new Savina 300 NIV. This product aimed for consistent and secure non-invasive mechanical ventilation in both acute and chronic care facilities.
Jul-2021: Mindray Medical International Limited launched its new turbine-based ventilator, the SV300 Pro. The product is easy to configure, simple to operate, and flexible in use. Moreover, it provides a comfortable and overall cure for all types of patients with different ventilation modes.
Jun-2020: Royal Philips introduced its mobile Intensive Care Units for India. The product would support the critical-care requirements of patients. Moreover, each pre-fabricated ICU has a space of nine beds which will be produced by Philips in India.
Mergers & Acquisition:
Apr-2021: Dragerwerk took over most of the share from STIMIT, a MedTech company that reinvents intensive care by empowering patients to breathe. This technology aimed to increase the company's expertise in the field of lung-protective ventilation.
Geographical Expansions:
Jan-2022: Getinge expanded its geographical footprints in Wayne, New Jersey by establishing a new Experience Center. The company aimed to utilize healthcare leaders with immense experience and their technologies. In addition to displaying how solutions enlarge efficiencies and amplify the patient experience.
May-2020: Hamilton Medical expanded its global reach in critical care ventilators near the U.S. offices in Reno, Nevada. Through this expansion, the company aimed to supply new production facilities and more life-saving machines to the U.S.
Trials & Approvals:
Jul-2023: Getinge AB obtained US FDA clearance for Servo-air Lite, a wall gas-independent non-invasive mechanical ventilator. This expanded the company's market reach in the US, enabling it to target the non-invasive hospital segment with its ventilation offering.
Market Segments covered in the Report:
By Mode (Volume, Thousand Unit, USD Billion, 2019-30)
By Component (Volume, Thousand Unit, USD Billion, 2019-30)
By Product Type (Volume, Thousand Unit, USD Billion, 2019-30)
By Age Group (Volume, Thousand Unit, USD Billion, 2019-30)
By End User (Volume, Thousand Unit, USD Billion, 2019-30)
By Geography (Volume, Thousand Unit, USD Billion, 2019-30)
Companies Profiled
Unique Offerings from KBV Research